Company: NCEL
Filing Date: 2025-05-16
Form Type: 20-F
Source: 0001213900-25-044868
Chunk: 343

Company: NewcelX Ltd.
Filing Date: 2025-05-16
Form: 20-F
Item: Item 19
Chunk 343
---
.                                                                                                                                                                                
  97.1        Clawback Policy (filed as Exhibit 97.1 to Annual Report on Form 20-F filed May 15, 2024).                                                                                                             
  101*        The following financial information from the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2023, formatted in XBRL (eXtensible Business Reporting Language): (i) Balanc...  
  104*        Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                          

  Filed herewith  

  Furnished herewith  

SIGNATURES

The registrant hereby certifies
that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this
annual report on Form 20-F filed on its behalf.

  NLS Pharmaceutics Ltd.                                     
  By:                         /s/ Alexander Zwyer            
                              Alexander Zwyer                
                              Chief Executive Officer        
  By:                         /s/ Nicole Fernandez-McGovern  
                              Nicole Fernandez-McGovern      
                              Chief Financial Officer        

NLS PHARMACEUTICS LTD. AND SUBSIDIARIES

CONSOLIDATED FINANCIAL STATEMENTS

YEARS ENDED DECEMBER 31, 2024, 2023 AND 2022

F-1

NLS PHARMACEUTICS LTD.

CONSOLIDATED FINANCIAL STATEMENTS

                                                                                                                                 Page  
  Report of Independent Registered Public Accounting Firm (PCAOB ID 688)                                                         F-3   
  Report of Independent Registered Public Accounting Firm (PCAOB ID 1358)                                                              
  Consolidated Balance Sheets as of December 31, 2024 and 2023                                                                   F-4   
  Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2024, 2023 and 2022              F-5   
  Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the Years Ended December 31, 2024, 2023 and 2022      F-6   
  Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022                                     F-7   
  Notes to Consolidated Financial Statements                                                                                     F-8   

F-2

Report of Independent Registered Public Accounting
Firm

To the Shareholders and Board of Directors of